COMBINED MEDICATION, CONTAINING PROBUCOL AND TETRAZOLYLALKOXY-DIHYDROCARBOSTIRYL, SUPEROXIDE SUPPRESSOR EFFECTS
展开▼
机译：包含普鲁布考和四唑烷氧基-二羰基碳基化合物，过氧化物抑制剂的联合药物治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, pharmaceutics.;SUBSTANCE: invention relates to field of pharmaceutics and deals with combined medication, which includes combination of tetrazolyloxy-dihydrocarbostiryl of formula (1) ; and probucol, due to synergic effects of combination as superoxide suppressor.;EFFECT: obtaining combined medication for prevention and treatment of cerebral infarction, arteriosclerosis, renal disease and diabetes.;30 cl, 6 dwg, 4 ex
展开▼
机译：药物组合物技术领域本发明涉及药物领域并且涉及组合药物，其包括式（1）的四唑基-二氢羰基硬脂酸酯的组合。 和普罗布考，由于联合使用作为超氧化物抑制剂具有协同作用。;效果：获得联合用药用于预防和治疗脑梗死，动脉硬化，肾脏疾病和糖尿病。; 30 cl，6 dwg，4 ex
展开▼
